COMTRADE-DIGITAL-SERVICE
5.12.2016 09:02:48 CET | Business Wire | Press release
Comtrade Digital Services , the leading software engineering services and solutions provider, today announced that it has created an automated banking platform for one of the world’s leading messaging apps, Viber. The transformative new solution is set to shake up the payments world, allowing users to carry out a range of banking transactions entirely through a chat-bot.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161205005101/en/
With the tap of a finger, Viber users of participating banks will now be able to instantly send and transfer money. They will also be able to check their bank balance and access other banking services directly through the app. Recipients of Viber payments will be able to instantly retrieve the money sent to them by using a QR code at an ATM or going to their local branch.
Using agile methodologies, Comtrade Digital Services developed a banking solution with a chat-bot that can understand and process user requests instantly and securely. The product can be integrated directly with banks’ own digital platforms and will help them to compete with emerging Fintech companies. The solution also includes a client acquisition tool that will help banks attract younger customers, who will soon dominate the payments world. The project was completed in just three months.
The banking platform is part of Viber’s recently launched business-oriented platform, ‘Public Accounts’, which allows businesses, brands and individuals to interact with potential customers via the messaging app in a direct, personalised and intuitive manner.
Oliver Lynch, Business Development Director, Comtrade Digital Services, said: “This solution is going to transform the payments world for retail banks, payment processors and their customers. Most banks now have a mobile app, but they don’t provide such innovative, instant payment options as this. This is the only messaging platform that, through an API, can be directly integrated with banks’ existing digital banking channels.
“At Comtrade Digital Services, we are constantly telling businesses that they must be willing to embrace and drive digital transformation in order to stay ahead. That is exactly what Viber has done and I expect many will follow. This marks a whole new era of banking and we can expect a significant proportion of the world’s micro transactions to be carried out over messaging apps and social media platforms in the future.
“Now, it is time for the world’s banks to welcome this new era and seek innovative solutions that will help them retain and attract customers – or be left behind.”
Elad Kojocaru, VP Marketing, Viber, said: “Viber started out as an app that connects people. Now, we are introducing a way for people to start connecting with businesses and brands through the launch of our Public Accounts service. Thanks to innovative technology partners such as Comtrade Digital Services, we enable businesses from traditional industries, such as banking, to enter the instant messaging era and interact with their customers in new ways.”
- ends -
About Comtrade Digital Services
Comtrade Digital Services is part of Comtrade Group, a leading IT provider with offices in 11 countries across Europe and North America. The group was established in 1990 and operates through 16 companies with a global staff base of over 1,500.
Comtrade Digital Services is the trusted developer of some of the world’s most renowned businesses, providing end-to-end technology products and solutions across a number of industries including government, financial institutions, healthcare, mobility, travel and logistics. By providing strategic software engineering services, Comtrade Digital Services accelerates innovation and helps companies address business challenges, embrace digital transformation and become industry leaders.
For more information on Comtrade Digital Services, visit www.comtradedigital.com
About Viber
Part of the Rakuten family, Viber freely connects users around the world with the people that matter to them most. With more than 800 million unique users on the platform, Viber allows people to connect in the way that works best for them, whether that’s through individual messaging, video calls or group chats, or following brands and celebrities on Public Accounts. Viber can be used on iPhone® , iPad® , Android™ phones and tablets, Windows Phone, Windows® , Windows 8® , Mac, and Linux devices over mobile or WiFi connections.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161205005101/en/
Contact:
For Comtrade Digital Services
Helen Morrogh
Comit
Communications & Marketing
Tel: +353 1 2157677
Mob: +353
85 7814755
Email: helen@comit.ie
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Samsung Bioepis Announces Positive Preliminary Phase 1 and Phase 3 Data for SB27, a Proposed Biosimilar to Keytruda (Pembrolizumab)29.6.2026 09:19:00 CEST | Press release
Phase 1 study demonstrated pharmacokinetic (PK) equivalence between SB27 and Keytruda; Phase 3 study demonstrated equivalent objective response rate (ORR) at Week 24Phase 1 and Phase 3 studies expected to be completed within 2026 Samsung Bioepis Co., Ltd. announced today that the Phase 1 and Phase 3 studies on SB27, a proposed biosimilar to Keytruda1 (pembrolizumab), have met their primary endpoints. “We are excited to announce preliminary results from the Phase 1 and Phase 3 studies for SB27, our pembrolizumab biosimilar candidate. These topline positive results reinforce our scientific expertise and leadership in biosimilar development,” said Donghoon Shin, Executive Vice President and Head of Clinical Sciences Division at Samsung Bioepis. “We are on track to complete both Phase 1 and Phase 3 studies within this year. Leveraging our robust quality management system, we remain committed to advancing our biosimilar portfolio to broaden access to life-saving biologic medicines for patie
IQM Named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment29.6.2026 09:00:00 CEST | Press release
IQM today announced it has been named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260629748732/en/ IQM named a major player in the IDC MarketScape IQM believes this recognition comes as institutions worldwide move quantum computing out of shared cloud access and into infrastructure they own and operate themselves. IQM calls this Production Quantum: full-stack, open-architecture superconducting systems deployed on premises, inside customers' own data centers and HPC environments, where organizations own the hardware, build internal expertise, and run quantum processors alongside their existing classical infrastructure. According to the IDC MarketScape, "For institutions building long-term quantum programs, this means the workflows and intellectual property developed on IQM hardware remain portable." The report further advises: "Consi
Zambon Announces Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations29.6.2026 09:00:00 CEST | Press release
Positive CHMP opinion is based on data from the Phase 3 RISE-PD trial, which demonstrated significantly more “Good ON” time with fewer daily doses compared with immediate-release levodopa/carbidopa More than one million people are living with Parkinson’s disease in the European Union, and over 80% experience motor fluctuations during the course of their disease, highlighting the need for additional treatment options Hopledo® contains a unique formulation combining immediate-release granules and extended-release pellets, providing both a rapid onset of action and a longer duration of effect, sustaining the levodopa therapeutic effect for a longer period of time If approved, Zambon expects to make Hopledo® progressively available to patients with Parkinson’s disease across Europe starting October 2026 Zambon today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a marketing authorization by the European M
Enhertu® Approved in the EU as First Tumor Agnostic HER2 Directed Therapy and Antibody Drug Conjugate for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors29.6.2026 08:30:00 CEST | Press release
Approval based on three phase 2 trials of Daiichi Sankyo and AstraZeneca’s Enhertu that demonstrated clinically meaningful responses across a broad range of tumors Enhertu now approved for six indications in the EU Enhertu® (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from subgroups of patients with HER2 positive (IHC 3+) tumors across thr
Beerenberg Prevails in Patent Case Against Aspen Aerogels29.6.2026 07:00:00 CEST | Press release
The ruling confirms that Beerenberg did not infringe Aspen Aerogels’ patents. The Korean Patent Court has invalidated three of Aspen Aerogels’ patents related to improved hydrophobic aerogel material. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260628192007/en/ Beerenberg delivers high-end insulation solutions built for performance, reliability, and long-term value. (Photo: Beerenberg) The ruling confirms the conclusion of the Intellectual Property Trial and Appeal Board (IPTAB) that the patents did not meet the necessary requirements for patentability. Beerenberg, which specializes in high-end insulation products, welcomes the court’s decision. “We are pleased that the case has now been concluded and that any uncertainty regarding the infringement claims has been removed,” says CEO Arild Apelthun. About Beerenberg Beerenberg has delivered cost-efficient solutions to a wide range of industrial enterprises for 49 years. Th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom